Business
Agenus Announces Appointment of Tom Harrison to Board of Directors
Advertising Veteran Tapped to Elevate Awareness of Agenus and Its Innovative Pipeline LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (NASDAQ: AGEN), a
About this update from Agenus Inc.
[{"type":"text","content":"\nAdvertising Veteran Tapped to Elevate Awareness of Agenus and Its Innovative Pipeline\n\n\n LEXINGTON, Mass.--(BUSINESS WIRE)--\nAgenus Inc. (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced the appointment of Tom Harrison to its Board of Directors. Mr. Harrison brings a wealth of experience and a proven track record in healthcare advertising, branding, and strategic advising.\n\n\nTom Harrison's Background Highlights:\n\n\n\nChairman Emeritus of Diversified Agency Services (DAS), Omnicom Group Inc.: Harrison led the world's largest group of marketing services companies, overseeing an unparalleled range of services including public relations, crisis management, branding, and healthcare advertising. Under his leadership, DAS grew to become the largest division within Omnicom Group, generating annual revenues of over $6 billion.\n\n\n\nExperience in Leading Marketing Services Companies: Harrison's tenure at DAS saw the division expand to over 5,000 worldwide clients, accounting for more than 50% of Omnicom's total revenues. He acquired and led a group of companies that became influential in their respective disciplines.\n\n\n\nProven Track Record in Healthcare Advertising: Before joining Omnicom, Harrison co-founded Harrison & Star Business Group, which became the most successful and rapidly growing agency in the healthcare industry. His unique approach fused high science with high creativity, positioning the agency as a leader in the market.\n\n\n\nSenior Operating Partner at Merida Capital Partners: In his current role, Harrison focuses on strategic and operational advising across Merida's portfolio companies, contributing his expertise to the dynamic cannabis industry.\n\n\n\nIn addition to his role at Merida Capital Partners, Mr. Harrison serves on the boards of AFC Gamma and Acurx Pharmaceuticals.\n\n\n“We are thrilled to welcome Tom Harrison to our Board of Directors,” said Garo Armen, PhD, Chairman and CEO of Agenus. “Tom’s extensive experience in healthcare advertising and strategic advising, combined with his proven leadership skills, will be invaluable as we continue to advance our mission of harnessing the power of the immune system to bring innovative therapies to patients.”\n\n\nEducating the World About Agenus and Our Pipeline\n\n\nAs Agenus ...